Skip to main content
. 2023 Sep 14;15(9):e45241. doi: 10.7759/cureus.45241

Table 3. Cumulative 1-year outcomes of MRA Vs no MRA.

MRA, minerolcorticoid receptor antagonist

  MRA No MRA
The cumulative 1-year incidence of heart failure hospitalization 18.7% HR, 0.70; 95% CI, 0.60-0.86; P < 0.001 24.8%
The cumulative 1-year incidence of the primary outcome 28.4%; HR, 0.81; 95% CI, 0.70-0.93; P = 0.003 33.9%